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Chemical crosslinks in collagens resulting from binding of advanced glycation end-products, have long been presumed to alter the
stiﬀness and permeability of glycated tissues. Recently, we developed a stochastic mechanical model for the response and failure of uniax-
ially deformed sciatic nerve tissue from diabetic and control rats. Here, we use our model to determine the likely correlation of ﬁbril
glycation with failure response, by quantifying statistical diﬀerences in their response. Our four-parameter model describes both the
non-linear toe region and non-linear failure region of these tissues; the four parameters consist of (1) collagen ﬁbril alignment, (2) ﬁber
bundle waviness, (3) Weibull shape parameter for ﬁbrillar strength, and (4) modulus-normalized Weibull scale parameter for ﬁbrillar
strength. Using an equal load sharing model we ﬁnd that diabetic and control tissues had shape parameters of 9.88 ± 5.50 and
4.33 ± 3.67 (p = 0.043), respectively, and scale parameters of 0.28 ± 0.07 and 0.58 ± 0.25 (p = 0.033), respectively, implying that the dia-
betic tissue behaves in a more brittle manner, consistent with more highly crosslinked ﬁbrils. We conclude that biochemical crosslinking
directly aﬀects measured mechanical properties. Further, this mechanical characterization may prove useful in mapping alterations in
stiﬀness and permeability observed in glycated tissues.
 2006 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.














A clear pathway from the binding of advanced glycation
end-products (AGEs) to alterations in the mechanical
response of collagenous tissue has not yet been directly
established, though they are clearly linked. Glycation-
induced crosslinkings of ﬁbrillar collagens of types I, III,
V and XI [2–7] have been implicated, for example, in stiﬀ-
ening of skin [8,9] and reduced fracture toughness in bone
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E-mail address: amsastry@engin.umich.edu (A.M. Sastry).have been shown to amplify the eﬀects of collagen glyca-
tion [11–13].
Nerve tissue contains 10–16% collimated collagen by
mass fraction [14–16]. This tissue undergoes glycation
[17,18], and exhibits altered mechanical properties, which
can be modeled using micromechanics [18,19]. The gross
mechanical properties of peripheral nerve [20,21] and colla-
gen ﬁbrils [22,23] have been quantiﬁed, but until our own
work, there was apparently no model correlating glycation
with mechanical properties at the tissue scale. Our method-
ology [18,19] was an application of classical bundle theory,
applied to the ﬁbrillar collagen of the nerve sheath [24–26].
The model was developed for the ﬁbril scale (Fig. 1), at
which the individual ﬁbrils may be modeled as spatially




































































Fig. 1. A series of ﬁgures from molecular scale to tissue scale. The letters C–H correspond to failure functions [24,25] used to predict failure at a larger
scale based on known properties at a smaller scale. The function F was chosen to represent the ﬁbril scale and is the scale of interest for the present work.
In (a) a left-handed triple helix of a ﬁbrillar collagen is depicted with glycine occupying every third position, see e.g., Refs. [81,82]. In (b) three triple helices,
see e.g., Ref. [83], self-assemble into (c) microﬁbrils of varying size prior aggregating into (d) ﬁbrils [55,84]. These ﬁbrils are then organized into (e) wavy
tape-like bundles in the epineurium that encase (f) whole nerve [50,85]. Dimensions given for ﬁbrils, bundles and whole nerve are those of rat sciatic nerve.
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present work is based on weakest-link scaling: a structure
comprised of distinct subcomponents placed in series fails
when one subcomponent fails. For structures comprised
of parallel subcomponents, all subcomponents in a given
link must fail before the entire structure fails. Here,
we model nerve tissue as a set of load-supporting collagen
ﬁbrils in parallel.
More generally, the order in which neighbors of broken
ﬁbrils rupture depends upon the nature of the ‘‘matrix;’’ in
this case, the matrix is the ground substance, which can be
assumed to have negligible mechanical eﬀect in collimated,
collagen-reinforced nerve tissues. For glycated tissues,
however, collagens can be assumed to exhibit substantial
crosslinking under these conditions, and so, the eﬀect is
similar to that of a matrix of low contrast ratio to the rein-
forcing phase (i.e., similar mechanical modulus). One
extreme strategy for modeling sequential rupture in such
a material is to assume that all surviving ﬁbrils carry load
equally (equal load sharing, or ELS). The other extreme
is to assume that only the ﬁbrils in the immediate vicinity
of the broken ﬁbril assume all overload (an example of
local load sharing, or LLS). These models correspond,
respectively, to a matrix of low or high contrast ratio. With
glycation, it can be reasonably hypothesized that response
of collimated collagens would be closer to LLS, due to
increased correlation of ﬁbrils.
In this work, we present a parametric constitutive failure
model for peripheral nerve, to test this hypothesis, using
the following key variables: ﬁbril waviness, as deﬁned by
the ratio between the spatial amplitude and ﬁbril periodic-
ity, ﬁbril angle with respect to the primary tissue axis, Wei-
bull shape parameter, and Weibull scale parameter. OtherE
D
variables included are collagen ﬁbril modulus, tissue scale
collagen density, and microscale packing density [19]. The
model is capable of capturing the full behavior of the
non-linear behavior of the nerve tissue from the toe region,
through the linear region and up to failure. The ﬁbril wav-
iness and ﬁbril angle capture the shape of the toe region,
while the Weibull scale and shape factors describe the fail-
ure region.
1.1. AGE binding of collagens
The basis for the presumably increased mechanical cor-
relation of glycated ﬁbrils is the known increase in AGE
binding in blockage of binding sites of extracellular matrix
(ECM) proteins such as collagen IV and laminin, impeding
cell adhesion, growth, and tissue remodeling [27]. AGE-
speciﬁc ﬂuorescence and enzyme-linked immunosorbent
assay (ELISA)-based binding have been shown to increase
with time in the coronary collagen of diabetes-induced rats
[28]. ELISA and solubility assays have been used to show
that collagen crosslinks form both in the presence and
absence of either free glucose or oxygen or a combination
of glucose and oxygen [4]. Overall, extensive chromatogra-
phy experiments with high performance liquid chromatog-
raphy have resulted in the identiﬁcation of over 30 distinct
AGEs [29,30]. Indeed, the presence of AGEs coincident
with glucose exposure has been shown to stiﬀen human
skin exposed to glucose-6-phosphate in vitro by as much
as 80% [9] and rat tail tendon by 100% [31] in vitro, and
to diminish stiﬀness by 50% and strength by 29% in healing
rat femoral bone, in vivo [10]; the crosslinks that are pre-
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for reducing the repair rate in bone by altering the kinetics
of collagenases as well as collagen self-assembly mecha-
nisms responsible for tissue remodeling.
1.2. Measurements in diabetic tissues: prior art
Collagen upregulation has been measured in explanted
human ﬁbroblasts in the presence of diabetic-level glucose
concentrations, in vitro, at both the translation and tran-
scription levels for Type III collagen and ﬁbronectin, but
not Type I [32]. Upregulation has also been documented
in vivo in rat skin studies, where higher glucose concentra-
tions in diabetic animals have been implicated in higher,
non-speciﬁc collagen concentrations, based on hydroxy-
proline levels. Upregulated Type I collagen and ﬁbronectin
with elevated glucose concentrations has also been mea-
sured in explanted sciatic rat nerve tissue, via Northern
hybridization [33]. Type VI collagen accumulation in dia-
betic human and rat nervous tissues has further been quan-
tiﬁed by immunoelectron microscopy; Type IV translation
upregulation has been quantiﬁed in rat neural cells [34].
Morphologically, collagen ﬁbril diameter enlargement
has also been quantiﬁed in a number of models for diabe-
tes. In an in vivo rat model, larger-than-normal, non-
speciﬁc (Type I/Type III) collagen ﬁbril diameters were
measured in diabetic rat endoneurium via transmission
electron microscopy (TEM) [35]. This was also found
in vivo in diabetic humans with TEM [36], and both
in vivo and in vitro with rat tail tendon with atomic force
microscopy (AFM) [3] and ﬁnally, in vitro in endoneurium
and epineurium in two diabetic rat models with AFM [17].
These morphological alterations are presumed to result
from AGE binding and subsequent irreversible crosslink-
ing of collagen. Collagen has naturally occurring crosslinks
in the form of dehydrohydroxylysinonorleucine [37,38].
Portions of the collagen molecule, not typically crosslinked
by lysyl oxidase, however, can become irreversibly cross-
linked in the presence of glucose [39–41]. When exposed
in vitro to reducing sugars such as glucose, ribose and gly-
ceraldehydes, rat tail tendon has shown a radial expansion
of collagen ﬁbril lattice, due to covalent bonding of the
sugar with the lysyl and hydroxylysyl groups of the colla-
gen, leading to crosslinks [42].
In recent work using liquid chromatography/mass
spectroscopy, over 20 advanced glycation end products,
in particular those forming crosslinks such as GOLD (gly-
oxal-derived lysine dimer), MOLD (methylglyoxal-derived
lysine dimer), and DOLD (3-deosyglucosone-derived lysine
dimer) were quantiﬁed in human blood plasma samples
[43]. If such a technique could be used to account for all
crosslinks in structural proteins such as collagen, a non-
destructive or minimally invasive method for assessing
AGE concentration could be used to predict mechanical
properties in heavily glycosylated tissue.
Methods such as detection with ﬂuorescence or autoﬂu-
orescence have also been used to determine the relative







the biochemistry of these crosslinks has not been fully elu-
cidated. Fluorescence emission has been correlated with
intermolecular spacing in corneal collagen; ﬂuorescent
emission increased with age as did intermolecular spacing,
presumably due to an increase in crosslink density [45].
More recent work [46] has employed an immunochemical
detection method to detect AGEs. And most recently a
positive correlation has been shown [47] between autoﬂuo-
rescence in skin at that 440 nm range and the amount of
pentosidine, a known crosslinking agent [48]. However,
the absorption spectra investigated may have overlapped
with that of other ﬂuorophores such as nicotinamide ade-
nine dinucleotide (NADH) and hemoglobin.
1.3. Modeling and hypotheses
Though we expect glucose-induced crosslinking to pro-
duce classically altered mechanical response in collagen-
reinforced tissue, our prior work [18] showed no signiﬁcant
diﬀerences in mechanical response between diabetic and
control tissues up to 40% strain. This strain is nearly coin-
cident with the strain required to ‘‘straighten’’ collagen
ﬁbers, which exhibit signiﬁcant waviness; we may presume
that after this point, the mechanics of the actual crosslinks
are investigated.
In the present work, we perform simulations and exper-
iments to determine the behavior of the collagens sur-
rounding nerve tissue. Our hypotheses are:
(1) Diabetic nerve tissues exhibit signiﬁcantly greater
shape parameters than normal nerve tissues. Qualita-
tively, this means that the stress–strain curve of the
diabetic tissue will be more sharply peaked at failure.
(2) Diabetic nerve tissues exhibit signiﬁcantly lower
failure-stress-to-modulus ratios than normal nerve
tissues.
(3) A local load sharing rule will have a better goodness-
of-ﬁt for the stress–strain responses of diabetic nerve
than controls; conversely, the equal load sharing rule
will produce stress–strain responses that ﬁt the con-
trol curves better than the diabetic curves.2. Methods
Our model employs the Weibull distribution as devel-
oped classically [49] and as later applied to composite
materials [24,25], assuming parameters at the ﬁbril scale
(Fig. 1d, Table 1). Data from our own experiments on
whole rat sciatic nerve from diabetic and control animals
[18,19] were compiled for model input. Prior to this, pub-
lished collagen images [50] were analyzed to guide our esti-
mations of collagen ﬁbril bundle morphology. Published
failure strengths of collagen ﬁbrils were found to range
from 2 to 70 MPa [22,51,52]. Collagen ﬁbril stiﬀnesses were
also taken from the literature, for reassembled ﬁbrils (1–
6 MPa) [53] and bovine Achilles tendon (430 MPa) [22].



















































1 nm 0.5 nm
Alpha
helices
1.4 nm 300 nm C 1400 1
Triple
helices
4 nm 300 nm D 1 3
Microﬁbril 10 nm 600 nm E 1 5–17
Fibril 20–150 nm <1 mm F 10,000 50–2000
Bundle (1–5) ·
(2–20) lm
<10 mm G 1 200–70,000
Nerve 1 mm <20 mm H 1 500–5000
Values for m and n represent the number of structural elements from the
preceding structural scale that comprise the given structure. For example,
approximately 5–17 ﬁbrils comprise a microﬁbril in parallel and a
microﬁbril has length on the order of one triple helix. Values given for
collagen ﬁbril diameter, bundle dimension, and nerve diameter are for rat
sciatic nerve.
Fig. 3. A molecular view of collagen, where three left-handed helices form
a right-handed triple helix held together by hydrogen bonds (NCBI
database, 2005). At the secondary scale of collagen, where left-handed
alpha helices form and glucose, or another monosaccharide, may
spontaneously form a open-loop structure, freeing an aldehyde which
has the potential to form a Schiﬀ base and ﬁnally an Amadori product or
advanced glycation end-product (AGE) [30] with one of the over 1000
nitrogen atoms of each collagen molecule which occupy every third atomic
position of the peptide chain.
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as the three-dimensional packing order, were taken from
published values determined via X-ray diﬀraction [54,55].
We made the following assumptions in our model for
whole-nerve response: (1) collagen ﬁbrils are contiguous
within a typical (10 mm) tissue sample (Fig. 2); (2) the
ﬁbril scale is the functional scale for stiﬀ elements within
the tissue; (3) ﬁbril waviness can be modeled adequately
as ﬁnite and periodic functions; and (4) the load-sharing
interdependence of ﬁbrils can be assumed to fall within
the extreme bounds of ELS and LLS. Also, the following
assumptions were implicit in our model: (1) crosslinks
within triple helices aﬀect the axial properties; and (2) tis-
sues containing larger-diameter ﬁbrils are not necessarily
stiﬀer, since the larger diameters result mainly from decora-
tions of ECM proteins (Fig. 3) such as Amadori products



















Fig. 2. A schematic of two possible mechanisms for load transfer within
collagenous tissue: (a) photograph of rat sciatic nerve being tested
uniaxially for the current study shows (b) load transferred solely within
ﬁbrils vs. (c) load transferred via shear within matrix among ﬁbrils.
Adapted from Ref. [86].E
D
Tissue response was simulated by selecting values for the
following parameters (Table 2): average ﬁbril modulus, Ef ,
collagenous area of nerve, Ac, packing fraction of collagen,
f, average, c, and standard deviation, rc, of collagen ﬁbril
bundle angle, c, average, a, and standard deviation, ra, of
collagen ﬁbril amplitude, a, Weibull modulus, x0, and Wei-
bull shape parameter, a. Ideally, Ef , Ac and f are known for
a given tissue sample a priori. In this work, Ac was set to
0.1, which is near the lower end of the literature values;
for example, a value of 0.106 was reported for human pel-
vic cavity nerve [14], a value of 0.16 was found by for
human posterior tibial nerve [15] and a value of 0.15
was reported for adult Sprague–Dawley rat sciatic nerves
[16]. The packing fraction of collagen within the collage-
nous portion, f, was set to 0.7, an approximation made
after analysis of images of diabetic and non-diabetic
BioBreeding rats [35], the same species used in this study.
The value of Ef was taken directly from data from
our own uniaxial stress–strain experiments, and calculated
from
Ef ¼ Acf rH  rLeH  eL ; ð1Þ
for each tissue specimen, where eL and rL represent the
lower deviation from linearity on the stress–strain curve
and eH and rH represent the upper deviation from linearity.
Sinusoidal ﬁbrils were modeled as 10 connected line seg-
ments, denoted by vectors
u ¼ f0; 0:1; 0:2; . . . ; 1:0g; . . . ; 2p; and ð2Þ





















































Measured, estimated and calculated parameters used as input to the
mechanical model of peripheral nerve
Parameter Value Description
Measured DN 1 mm Whole nerve diameter
eL 0.07–0.37 Lower strain limit of linear
portion of stress–strain curve
eH 0.15–0.63 Upper strain limit of linear
portion of stress–strain curve
rL 0.15–0.63 Lower stress limit of linear
portion of stress–strain curve
rH 0.15–0.63 Upper stress limit of linear
portion of stress–strain curve
EN 4–50 MPa Elastic modulus of whole nerve
Estimated Ac 0.1 Area fraction of collagenous
portion of nerve
f 0.7 Area packing fraction of
collagen within collagenous
portion of nerve
Calculated EF 100–500 MPa Elastic modulus of
collagen ﬁbrils
Model c 0 Average ﬁbril angle in
radians (zero for all
simulations)
rc 0–0.82 Standard deviation of ﬁbril
angle in radians (0 = parallel
to nerve axis)
a 0–1 Fibril amplitude normalized
to ﬁbril sinusoidal
spatial wavelength
ra 0–0.35 Standard deviation of
ﬁbril amplitude
Ex 0–1 Normalized ﬁbril Weibull
scale parameter
strength/modulus
a 0–10 Fibril Weibull shape parameter
Measured parameters were taken directly from uniaxial tension stress–
strain curves of whole sciatic nerves from BioBreeding rats [18]. Estimated
value for Ac was taken from [14]. Estimated value for f was taken from
[35]. The value for Ef was calculated based on Eq. (1) and is used to match
the linear region of the stress–strain curve. Of the parameters used to
deﬁne the model, c, rc, a, ra describe the shape of the toe region and the





























Fig. 4. A family of curves depicting the eﬀects of average ﬁbril amplitude,
a, and ﬁbril amplitude standard deviation, ra (four leftmost curves) on the
behavior of the toe region. The two rightmost solid curves depict the
eﬀects of the Weibull shape, a, and scale, Ex parameters on model results
for matching uniaxial tension stress–strain curves for whole rat sciatic
nerve. Generally, large a and large Ex result in a high, tight failure peak,
whereas a small a and small Ex result in a low, broad failure plateau.
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Owhere a is absolute ﬁbril spatial amplitude. To simulate the





¼ cos c  sin c






prior to simulated straining.
Eleven ﬁbrils were used in each simulation; this value
produced a satisfactorily smooth toe region stress–strain
match with experimental results, and also resulted in a trac-
table computation (1–10 s on the computation platform
described at the end of this section). Greater angles
required longer computation times. Since statistics for both
normalized ﬁbril amplitude, a, and ﬁbril angle, c, aﬀect the







tions we systematically varied the non-dimensionalized




where L is the ﬁbril period. Angle standard deviation, rc,
was varied from 0 to 0.85 (radians) in 40 increments, fol-
lowing our prior work [19].
This range was found to be suﬃcient to cover the entire
range to minimize root mean square (RMS) error between
simulated and experimental curves. Though solutions min-
imizing RMS error are frequently non-unique, i.e., there
are several combinations of a and ra or a and rc that
map to a given RMS error, for the two domain variables,
a and ra or a and rc, the RMS error is single-valued. We
bounded the combinations of these variables that mini-
mized within 2.5% (40 values per axis) of the range of val-
ues of physiological interest for this tissue. To verify that a
local minimum was not mistaken for the global minimum,
several simulations with four times the discretization in
each dimension were run. Simulations only up to eH
(Fig. 4) were run to ﬁt a and ra in one simulation set, then
combinations of a and rc that minimized RMS error in a
second simulation set were found. In this manner, we were
assured of bounding all reasonable values of our geometry
variables. For example, curve 1 in Fig. 4 has a relatively
smaller a or rc than curve 3. Fig. 5 depicts a typical consti-
tutive response from a control and a diabetic sample, and
demonstrates the ability of the combined ﬁbril-scale mor-
phology stochastic failure prediction model to capture
and parameterize behaviors as diverse as those shown.
Once the toe region was mapped with a and ra or a and
rc we used the Weibull distribution to model the ﬁbril
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Fig. 5. Representative failure stress–strain curve from (a) control and (b) diabetic whole nerve uniaxial tests depicting strain limits, eL and eH of linear
portion of curve used to determine whole nerve modulus, EN. Initial toe region stress data points less than 0.5% of maximum stress were removed since
data were taken from nerves which had been strained to 10%, 20%, 40%, and 80% prior to being stretched to failure. Vertical post-failure tail of control
curve resulted from termination of test prior to complete tissue separation.
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361where x0 and a, are scale and shape parameters, respec-
tively. We determined the ranges of x0 and a that produced
RMS minima for all experimental curves, by extending
them until global minima were found. Global minima for
each case were inspected visually to verify that the numer-
ical best ﬁt matched the constitutive curve. To reduce
excessive computation time and minimize spurious results
resulting from running simulations to total failure strain
eF (Fig. 4), simulations were run to a stress, rU, deﬁned
as 95% of the maximum stress attained in the experimental
data. For convenience, x0 was normalized to ﬁbril modu-
lus, Ef and ﬁbril strength, Ex, was deﬁned as C
















RIt is well established that a composite material with
many, small independent load-carrying members is less
likely to fail abruptly than one with a few large members
whose overload is highly dependent on local failure [24].
In our simulations, we used the extreme LLS and ELS
schemes mentioned previously, to model tissue failure in
the nerve. A classic model [25] allows for a composite to
be modeled as a chain of bundles, where the links of the
chain act in series and the bundle ﬁbrils act in parallel.
Essentially, if all the ﬁbrils, F, within any of the bundles,
G, fails, then the composite, H, fails via376







385where n is the number of ﬁbrils in parallel for a given bun-
dle G in a composite with m bundles (Table 1). Our imple-
mentation was slightly modiﬁed in that we assumed that
ﬁbrils and thus bundles were tissue-spanning (i.e., m = 1)
at both the tissue-bundle scale and at the bundle-ﬁbril
scale. A full treatment is given in Refs. [24,25] but, brieﬂy,




OG1ðxÞ ¼ F ðxÞ
G2ðxÞ ¼ 2F ð2xÞF ðxÞ  F ðxÞ2
G3ðxÞ ¼ 6F ðxÞF 3x
2
 





where F(x) is the familiar Weibull function (6).
Closed-form solutions for G with n > 9 become intracta-
ble, and those which include solutions for non-straight
ﬁbrils do not exist; thus, binning ﬁbril behavior in a small
set (11) was identiﬁed as a practical solution. As an exam-
ple of an extension to this model which we will mention,
but not explore here, a similar solution could be con-
structed for bond failure, within a single type I collagen
alpha helix, according to
Dm;nðxÞ ¼ 1 ½1 C3ðxÞn; ð10Þ
where D represents the failure probability function of three
bound collagen alpha helices, C. This equation could be
used to bridge scales C and D, (Fig. 1) where n in this case
could be further compartmentalized into its approximately
1100 covalent peptide bonds within a single triple helix plus
its variable (50–100) crosslinks.
The mathematical descriptions of the ELS and LLS are
given as follows. As the name implies, in ELS, when one
ﬁbril breaks, all the surviving ﬁbrils share the remaining
load equally. In LLS, ﬁbrils neighboring a broken ﬁbril
sustain the majority of the load, shielding the other ﬁbrils.
This is the equivalent of a stress concentration factor. In
simulations here, we usedKr ¼ 1þ r
2
: ð11ÞSo in our example with 11 ﬁbrils, in ELS, for one broken
ﬁbril, K for each remaining ﬁbril was 11/10. But in LLS, K
for the two ﬁbrils nearest the broken one was 1.5, with the
remaining nine having a K = 1. Since each simulation
employed a random variable mapped into the Weibull dis-


















































Model input parameters and model results for diabetic (n = 8) and control
(n = 6) uniaxial testing and simulations
Model Parameter Diabetics Controls
(a) LN (mm) 10.0 ± 0.0 10.0 ± 0.0
DN (mm) 1.18 ± 0.08 1.23 ± 0.07
eL 0.11 ± 0.04* 0.25 ± 0.10
eH 0.20 ± 0.05* 0.40 ± 0.18
rL (MPa) 0.88 ± 0.40 0.96 ± 0.25
rH (MPa) 2.83 ± 1.07 2.39 ± 0.60
EN (MPa) 25.9 ± 14.1 16.1 ± 5.8
EF (MPa) 365 ± 167* 169 ± 75
A 0.050 ± 0.031* 0.171 ± 0.097
Wv (kJ/m
3) 24.73 ± 23.17* 62.39 ± 33.88
(b) r = ce2 + de c 71.1 ± 51.1* 23.3 ± 20.6
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where r^ is the vector of experimental stress values and r is
the vector of simulated stress values. These were then con-
tour mapped and the minima reported according to [57].

























d 1.49 ± 1.02 1.58 ± 0.52
R2 0.979 ± 0.014 0.983 ± 0.013
(c) rc = 0 a 0.51 ± 0.12* 0.63 ± 0.06
ra 0.12 ± 0.03 0.20 ± 0.10
RMS 0.641 ± 0.272 0.457 ± 0.089
R2 0.998 ± 0.001 0.998 ± 0.001
(d) ra = 0 a 0.43 ± 0.09 0.53 ± 0.09
rc 1.51 ± 0.39 1.57 ± 0.17
RMS 0.561 ± 0.235 0.107 ± 0.000
R2 0.987 ± 0.005 0.988 ± 0.002
(e) ELS a 9.9 ± 5.50* 4.33 ± 3.67
Ex 0.28 ± 0.07* 0.58 ± 0.25
RMS 0.150 ± 0.130 0.162 ± 0.056
(f) LLS a 21.8 ± 3.87* 10.17 ± 10.91
Ex 0.30 ± 0.07* 0.73 ± 0.27
RMS 0.288 ± 0.293 0.284 ± 0.143
(a) Whole nerve diameter, DN strain and stress at the onset eL, rL and end
eH, rH, of the linear region, whole nerve modulus, EN and ﬁbril modulus,
EF, used as input to the simulations. Aspect ratio A, was deﬁned as the
width-to-height ratio of the failure curves. Strain energy, W v ¼
R
rde
under the toe region is also shown. (b) Results of quadratic curve ﬁtting of
toe region (up to eL) of unaxial test data from diabetic and control whole
rat sciatic nerves. (c) Results for RMS minimization with a and ra as
parameters (rc = 0). (d) Results for RMS minimization with a and rc as
parameters (ra = 0). (e) Results for RMS minimization of Weibull
parameters, a and Ex under equal load sharing (ELS). (f) Results for RMS









where e(UTS/2) is the width of the full failure curve taken
at a height of one-half the ultimate tensile stress, rUTS.
For each sample, a total of 6000 simulations, each taking
approximately 30 s on the Sun Blade-1000 (900 MHz, 2GB
RAM) platform, were run. To compare results between the
diabetic and control groups, Student’s unpaired two-
tailed t-tests were used, and p-values calculated for each
comparison.
3. Results
While our primary objective of this work is to demon-
strate that our modiﬁed Weibull–Harlow–Phoenix model
is useful for relating the macroscopic failure behavior of
soft biological tissue to the molecular scale modiﬁcations
in diabetic tissue, we realize that future work in this
area may include models employing a continuum mechan-
ics approach. As a matter of convenience for those using
such approaches, we have made a ﬁrst approximation as
to the shape of the toe region. The intent of this paper is
primarily to determine tissue-morphology-based parame-
ters, c and a, rather than the polynomial parameters that
follow.
Stress–strain curves were curve-ﬁtted to quadratic
equations
r ¼ ce2 þ de: ð14Þ
No constant term was included, because less than 0.5%
of maximum stress was truncated and shifted in the toe
region, since data were from nerves that had been previ-
ously strained. These results show that the quadratic term
was signiﬁcantly stronger (p = 0.038) in the diabetics
(Table 3). This trend was repeated when a cubic approxi-
mation was used. Using a cubic function to approximate
the toe region, increased R2 values of 0.998 and 0.999 for
diabetics and controls, respectively, were found. A quartic
model found increased R2 values to greater than 0.999. A
larger higher-order term implies that the onset of load hap-
pens more suddenly once a certain strain is reached,
whereas a stronger contribution from the linear term
implies that loading occurs more gradually.To study the eﬀects of actual ﬁbril geometry, amplitude,
a, and amplitude standard deviation, ra were found, up to
eH, for eight diabetic and six control specimens. A typical
result (Fig. 6) is shown, demonstrating that control tissues
(Fig. 6a) had both higher amplitude averages and standard
deviations than those of diabetics (Fig. 6b). To further
examine the eﬀects of actual ﬁbril geometry, amplitude
and angle standard deviation were also simulated to strains
up to eH for each specimen. A typical result (Fig. 7) reveals
a similar trend, with control specimens (Fig. 7a) requiring a
larger amplitude and standard deviation than those of dia-
betics (Fig. 7b), to minimize RMS error.
The relative responses resulting from ELS vs. LLS
assumptions in a typical control specimen can be seen in








































































Fig. 6. RMS error contour plot of results from ﬁtting a single rat sciatic nerve uniaxial stress–strain curve from (a) control and (b) diabetic specimens up
to eH, with parameters a (average ﬁbril amplitude) and ra (standard deviation of ﬁbril amplitude) holding c = 0. In all simulations, c ¼ 0. The plot is only
half-populated since, for example, in all simulations where a ¼ 0, ra = 0. Key features are that the combination of a and ra has been found that minimizes
RMS error: a ¼ 0:7, ra = 0.33 for control and a ¼ 0:525, ra = 0.115 for diabetic. The four icons on the boundary of the contour plot depict the
approximate ﬁbril geometry used to generate that region.












































Fig. 7. RMS error contour plot of results from ﬁtting a single rat sciatic nerve uniaxial stress–strain curve for (a) control and (b) diabetic specimens up to
eH, with parameters a (average ﬁbril amplitude) and rc (standard deviation of ﬁbril angle), holding ra = 0. In all simulations, c ¼ 0. Generally speaking,
larger amplitudes and variations in angle are found to best represent the more compliant control tissue, whereas smaller amplitudes and smaller variations
in angle are found to best represent diabetic tissue. The four icons on the boundary of the contour plot depict the approximate ﬁbril geometry used to
generate that region.
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Ngiven load, in the case of the LLS scenario (Fig. 8b) theﬁbrils must be stronger than in the ELS scenario
(Fig. 8a). Values of Ex and a for all diabetic specimens were
also plotted; a typical result for diabetic tissue (Fig. 9)
demonstrates that application of the LLS model implies
stronger ﬁbrils for a given load, to ﬁt experimental data.
In this case, the ELS assumption resulted in lower local
RMS errors, but to a lesser degree than was the case for
the control data.
Goodness of ﬁt, /, was evaluated as the diﬀerence
between the minimum RMS error value for each of the
two models, normalized by the LLS error:/ ¼ RMSLLS RMSELS
RMSLLS
: ð15Þ
The LLS model, in general, ﬁt the diabetic failure curves
better than the ELS model; the ELS model ﬁt control fail-
ure curves better than the LLS model (Fig. 10). Across all
samples, the ELS model had a lower RMS value; however,
when we compare the two models with (15) we see that this
diﬀerence is greater (i.e., relatively lower RMS ELS for
controls compared to diabetics). This supports Hypothesis
3. The aspect ratio, A, was found to diﬀer signiﬁcantly be-
tween diabetic failure curves and control failure curves,
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Fig. 9. RMS error contour plots of results of curves for varying Weibull parameters based on collagen ﬁbril strengths to ﬁt a typical stress–strain failure
curve from a diabetic animal for (a) equal load sharing and (b) local load sharing. Notice that even though the diabetic tissue has a greater failure strength,
its minimal Ex (normalized Weibull scale parameter) value is less than that of the control (Fig. 8) since its Ef (ﬁbril modulus) is greater (Fig. 5). The four
icons on the boundary of the contour plot depict the approximate shape of the Weibull cumulative distribution function used to generate that region.
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Fig. 8. RMS error contour plot of results of curves for varying Weibull parameters based on collagen ﬁbril strengths to ﬁt a typical stress–strain failure
curve from a control animal for (a) equal load sharing and (b) local load sharing. In (b) local load sharing the ﬁbrils must be stronger on average to carry
the same global load. The four icons on the boundary of the contour plot depict the approximate shape of the Weibull cumulative distribution function




















Fig. 10. A plot depicting relative goodness-of-ﬁt, /, (15) as a function of
failure curve aspect ratio, A as deﬁned in (13). Squares denote diabetic
results and circles denote control results. Three diabetic and control
stress–strain curves are shown. The solid line depicts a least-squares ﬁt to
the diabetic data. The dashed line is a least-squares ﬁt to the control data.
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As may be seen from the results of Table 3, Hypothesis 1
is supported by experimental evidence. Diabetic nerve
tissues exhibited a signiﬁcantly (p < 0.05) greater shape
parameter, a for ELS (9.88 vs. 4.33) and for LLS (21.81
vs. 10.17). The results of Table 3 also support Hypothesis
2; a signiﬁcantly (p < 0.05) lower modulus-normalized scale
parameter, Ex, was found in diabetic vs. control tissues,
for both ELS (0.28 vs. 0.58) and for LLS (0.30 vs. 0.73)
assumptions. Hypothesis 3 was also supported by experi-
mental and numerical ﬁndings; the normalized RMS error
for the LLS model for diabetics had a relatively lower error
than the ELS model. This implies that the diabetic nerves
behaved in a more brittle manner. Likewise, in support
of Hypothesis 3, the failure data for the control nerves
tended to ﬁt the ELS model better than it did the LLS
model. This implies that the ability of the ELS model to



















































































































10 B.E. Layton, A.M. Sastry / Acta Biomaterialia xxx (2006) xxx–xxx
ACTBIO 144 No. of Pages 13, Model 5+









the vicinity of failed ﬁbrils may oﬀer insight into the micro-
and nanoscale failure processes within collagenous tissue.
The broader implications of these results are as follows.
For more highly correlated ﬁbrils, either due to an increased
number of crosslinks or due to higher correlations within
individual triple helices, peripheral nerve would be more
likely to fail with elevated endoneurial ﬂuid pressure
(EFP). This relationship is suggested by prior literature
[58], though we have not studied the degree of the eﬀect of
this reduction in failure stress in light of very classic EFP
data.
Fibril modulus was assigned based upon whole-tissue
response and assumed collagen volume and packing frac-
tions. Ideally, a smaller specimen on the order of just a
few ﬁbrils, or a single bundle of almost purely collagenous
epineurium could be taken from the nerve sample and tested
separately to obtain a ﬁbril modulus. This approach would
not only allow insight into the degree to which glycation
aﬀects ﬁbril properties, but would also serve to narrow
the bounds on the load-sharing rule. As additional informa-
tion becomes available with advanced imaging and labeling
technologies, our methodology will be applied more readily.
There is extensive literature on the molecular modeling
of the elastic properties of collagen, see e.g., Refs. [59–61]
and failure mechanics of collagen, e.g., Ref. [52]. The incor-
poration of the results of such approaches would augment
our model by serving as a front-end reﬁnement to our lin-
ear elastic model of individual ﬁbrils, as well as a source of
failure distribution data to our Weibull curves. The eﬀect
of employing molecular mechanics simulations might
improve the accuracy of our model, and could serve to
reﬁne a bundle model of glycated collagen-reinforced tissue
to a model intermediate to extreme LLS and ELS behavior.
In previous work [19], we considered the sciatic nerve as
a pressure vessel where the transverse properties of this
pressure-vessel structure were considered. The main under-
lying assumption is that collagen is the major load-carrying
component of nerve. Similar approximations have been
made for other soft-tissue models based primarily on vol-
ume-fraction assumptions. For example, Ault and Hoﬀman
[63] assume that the protein elastin contributes negligibly to
mechanical behavior of tendon due to its low volume frac-
tion. A similar argument may be made for our neglect of the
contribution of cellular material in nerve. Experimental val-
ues of cellular material in individual axons [62] have shown
that the maximum force individual neurons can sustain is
on the order of 1 nN. With approximately half a million
neurons in a sciatic nerve, this represents a total force of less
than a mN, or a contribution three orders of magnitude
lower than the forces generated by the collagen matrix.
Neither continuum nor multiscale models developed to
date can provide the complete description we show here,
though each has speciﬁc strengths. Continuum models
are essentially phenomenological, as is our polynomial
curve-ﬁtting (Table 3) model, while the stochastic failure
model presented here registers individual substructures,







assigns individual collagen ﬁbrils, a mathematical contribu-
tion in the stress–strain curve, based on data from the
structures themselves. Attempts to model the viscoelastic
properties of peripheral nerve with continuum-mechanics-
based approaches [21,65], have the central shortcoming
of inability to incorporate ﬁbril load sharing. Multiscale
models, some even using seven or more parameters [66],
have been used to span the macro–microscale dimensions,
in tendon. As other authors have pointed out, however,
these methods neglect what may occur in the case of local
failure from overloading due to stochastic nature of the
material. A micromechanics-based model for mechanical
properties of connective tissue [67], and even an attempt
to quantify the toe region-to-failure curve for low volume
fraction reconstituted ECM [68] have also been proposed.
But the present model goes beyond that of traditional con-
tinuum approaches for modeling nonlinear tissues, see e.g.,
Refs. [69,70], and gives us a better understanding of how
the molecular scale of tissue aﬀects global properties for
the purpose of predicting how and where failure is likely
to occur.
One common diﬃculty in reporting results of soft tissue
experimental mechanics is the decision on where to mark
the ‘‘zero load’’ condition. Two methods include deﬁning
zero load at the precision limit of measurement of the device
recording load, or selecting some fraction of in vivo strain to
deﬁne zero load. The former has the diﬃculty that the mass
of the specimen is likely larger than the precision limit of the
measuring device; the latter has the diﬃculty that anatomi-
cal posture aﬀects in vivo strain, and thus is not an unambig-
uous or repeatable value.
In our tensile apparatus, specimens were suspended
above an analytic balance. The balance was tared while the
specimen was still slack, leaving a small fraction of the mass
supported by the scale. The mass of each specimen was
approximately 100 lN. If one-tenth of the specimen was
supported by the scale, this represents a force of 10 lN or
10E6 of our maximum loads of around 10 N. One might
like to know the true load during tensile testing normalized
to in vivo values. Such amethod would involve non-invasive
or minimally invasive imaging and sample marking prior to
sample excision, coupled with a method of replicating the
true in vivo loadingmode. Here, we have placed the zero load
condition at 0.5% of maximum load. This was identiﬁed as a
simple, convenient, consistent and repeatable method.
The terms most likely aﬀected by our choice of zero load
are the coeﬃcient c of (14) as well as the angle, g and ampli-
tude a terms. However, since a greater fraction of low-load
toe region was eliminated from the control specimens as
compared with diabetic specimens, this would only exag-
gerate the eﬀects found in Table 3. Another term likely to
be aﬀected by our choice of zero load is the strain-energy
term, W. The strain-energy term is less sensitive to the
selection of absolute zero than those mentioned above. If
the toe region were allowed to extend further to the left,
giving additional area under the stress strain curve, the ds
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of the curve. This change would be small compared to the
total area under the curve, regardless of the duration of the
straining. For the results of our experiments, the eﬀects
would be exaggerated since the control nerves tended to
have more protracted failure regions.
The modeling described here, in mapping the failure
mechanics of the tissue Weibull statistics, follows from
classic literature on rope, cable, and other engineered mate-
rials [71,72]. It is likely in the future that adaptation of such
models will become more common, as detailed investiga-
tion of the structure of tissue becomes possible. Indeed,
the biomechanics literature has shown a recent increase
in the application of micromechanics tissue models, see
e.g., Refs. [67,68,73]. Indeed, our work can explain the
recent ﬁndings [74] demonstrating that for collagenous tis-
sue such as bovine pericardium, that the stiﬀness of actual
collagen ﬁbrils is not measured until 10–15% strain.
Recent activity in failure mechanics modeling to extend
the ELS and LLS load sharing strategies [75,76], to greater
numbers of ﬁbrils and with novel strategies for parameter-
izing behavior that falls somewhere between the two
extremes, has appeared. An interesting extension of the
current work would be the application of these methods
of Refs. [63,64] to problems of biological relevance,
especially in the ﬁelds of disease modeling and tissue
engineering.
In conclusion, the central advantage of a microme-
chanics approach is that histological and anatomical data
can be used directly in mechanics models, and can further
allow direct use of biochemical data in prediction of
mechanical behavior. In the speciﬁc case of peripheral
nerve, alterations in function have been linked with axi-
ally several stretching; these include membrane potential
[77], compound nerve action potential [78], blood ﬂow
[79], and nerve conduction velocity [80]. When peripheral
nerve is compressed with a tourniquet [79] nerve conduc-
tion velocity also diminishes. The eﬀorts initiated here
may prove useful in interrogating a number of functional
losses in glycated peripheral nerves. More accurate exper-
imental data on intra- and interﬁbril mechanical proper-
ties as well as more extensive nanomorphological data
to resolve our tissue-spanning hypothesis will allow better
approximations for load sharing and ﬁber recruitment
during load, and ultimately, prediction of mechanical













This work was supported by the W.M. Keck Founda-
tion, the Whitaker Foundation and by an NSF PECASE








[1] Nanomanipulation and SPMs. Adv Mater 2000;12(15):1095–1095.
[2] Hadley J, Malik N, Meek K. Collagen as a model system to
investigate the use of aspirin as an inhibitor of protein glycation and
crosslinking. Micron 2001;32(3):307–15.
[3] Odetti P, Aragno I, Rolandi R, Garibaldi S, Valentini S, Cosso L,
et al. Scanning force microscopy reveals structural alterations in
diabetic rat collagen ﬁbrils: role of protein glycation. Diabetes Metab
Res Rev 2000;16(2):74–81.
[4] Sajithlal GB, Chithra P, Chandrakasan G. Advanced glycation end
products induce crosslinking of collagen in vitro. Biochim Biophys
Acta 1998;1407(3):215–24.
[5] Vasan S, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen
J, et al. An agent cleaving glucose-derived protein crosslinks in vitro
and in vivo. Nature 1996;382(6588):275–8.
[6] Yang SZ, Litchﬁeld JE, Baynes JW. AGE-breakers cleave model
compounds, but do not break Maillard crosslinks in skin and tail
collagen from diabetic rats. Arch Biochem Biophys 2003;412(1):42–6.
[7] Zieman SJ, Kass DA. Advanced glycation endproduct crosslinking in
the cardiovascular system: potential therapeutic target for cardiovas-
cular disease. Drugs 2004;64(5):459–70.
[8] Reihsner R, Melling M, Pfeiler W, Menzel EJ. Alterations of
biochemical and two-dimensional biomechanical properties of human
skin in diabetes mellitus as compared to eﬀects of in vitro non-
enzymatic glycation. Clin Biomech 2000;15(5):379–86.
[9] Reihsner R, Menzel EJ. Two-dimensional stress-relaxation behavior
of human skin as inﬂuenced by non-enzymatic glycation and the
inhibitory agent aminoguanidine. J Biomech 1998;31(11):985–93.
[10] Macey LR, Kana SM, Jingushi S, Terek RM, Borretos J, Bolander
ME. Defects of early fracture-healing in experimental diabetes. J
Bone Joint Surg Am 1989;71(5):722–33.
[11] Feldman EL. Oxidative stress and diabetic neuropathy: a new
understanding of an old problem. J Clin Invest 2003;111(4):431–3.
[12] Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR,
Baynes JW. Glycation, glycoxidation, and cross-linking of collagen
by glucose. Kinetics, mechanisms, and inhibition of late stages of the
Maillard reaction. Diabetes 1994;43(5):676–83.
[13] King RH. The role of glycation in the pathogenesis of diabetic
polyneuropathy. Mol Pathol 2001;54(6):400–8.
[14] Seyer JM, Kang AH, Whitaker JN. The characterization of Type I
and Type III collagens from human peripheral nerve. Biochim
Biophys Acta 1977;492:415–25.
[15] Fujii K, Tsuji M, Murota K. Isolation of peripheral nerve collagen.
Neurochem Res 1986;11(10):1439–46.
[16] Dumanian GA, McClinton MA, Brushart TM. The eﬀects of free fat
grafts on the stiﬀness of the rat sciatic nerve and perineural scar. J
Hand Surg-Am 1999;24A(1):30–6.
[17] Wang H, Layton BE, Sastry AM. Nerve collagens from diabetic and
nondiabetic Sprague–Dawley and biobreeding rats: an atomic force
microscopy study. Diabetes Metabol Res Rev 2003;19(4):288–98.
[18] Layton BE, Sastry AM, Wang H, Sullivan KA, Feldman EL,
Komorowski TE, et al. Diﬀerences between collagen morphologies,
properties and distribution in diabetic and normal biobreeding and
Sprague–Dawley rat sciatic nerves. J Biomech 2004;37(6):879–88.
[19] Layton BE, Sastry AM. A mechanical model for collagen ﬁbril load
sharing in peripheral nerve of diabetic and non-diabetic rats. ASME J
Biomech Eng 2004;126:803–14.
[20] Abrams RA, Butler JM, Bodine-Fowler S, Botte MJ. Tensile
properties of the neurorrhaphy site in the rat sciatic nerve. J Hand
Surg [Am] 1998;23(3):465–70.
[21] Wall EJ, Kwan MK, Rydevik BL, Woo SL, Garﬁn SR. Stress
relaxation of a peripheral nerve. J Hand Surg [Am] 1991;16(5):
859–63.
[22] Sasaki N, Odajima S. Stress–strain curve and Young’s modulus of a










































































































































12 B.E. Layton, A.M. Sastry / Acta Biomaterialia xxx (2006) xxx–xxx
ACTBIO 144 No. of Pages 13, Model 5+









[23] Pins GD, Christiansen DL, Patel R, Silver FH. Self-assembly of
collagen ﬁbers. Inﬂuence of ﬁbrillar alignment and decorin on
mechanical properties. Biophys J 1997;73(4):2164–72.
[24] Harlow DG, Phoenix SL. Chain-of-bundles probability model for
strength of ﬁbrous materials 2. Numerical study of convergence. J
Compos Mater 1978;12(July):314–34.
[25] Harlow DG, Phoenix SL. Chain-of-bundles probability model for
strength of ﬁbrous materials 1. Analysis and conjectures. J Compos
Mater 1978;12(April):195–214.
[26] Danielson HE. The statistical theory of the strength of bundles of
threads. I. Proc Roy Soc (Lond A) 1945;183:405–35.
[27] Brownlee M. Glycation products and the pathogenesis of diabetic
complications. Diabetes Care 1992;15(12):1835–43.
[28] Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical
detection of advanced glycosylation end products in vivo. J Biol
Chem 1992;267(8):5133–8.
[29] Ahmed N, Argirov OK, Minhas HS, Cordeiro CAA, Thornalley PJ.
Assay of advanced glycation endproducts (AGEs): surveying AGEs
by chromatographic assay with derivatization by 6-aminoquinolyl-N-
hydroxysuccinimidyl-carbamate and application to N-epsilon-carb-
oxymethyl-lysine- and N-epsilon-(1-carboxyethyl)lysine-modiﬁed
albumin. Biochem J 2002;364:1–14.
[30] Vlassara H, Palace MR. Diabetes and advanced glycation endprod-
ucts. J Int Med 2002;251(2):87–101.
[31] Bai P, Phua K, Hardt T, Cernadas M, Brodsky B. Glycation alters
collagen ﬁbril organization. Connect Tissue Res 1992;28(1–2):1–12.
[32] Benazzoug Y, Borchiellini C, Labat-Robert J, Robert L, Kern P.
Eﬀect of high-glucose concentrations on the expression of collagens
and ﬁbronectin by ﬁbroblasts in culture. Exp Gerontol
1998;33(5):445–55.
[33] Muona P, Peltonen J, Jaakkola S, Uitto J. Increased matrix gene
expression by glucose in rat neural connective tissue cells in culture.
Diabetes 1991;40(5):605–11.
[34] Muona P, Jaakkola S, Zhang RZ, Pan TC, Pelliniemi L, Risteli L,
et al. Hyperglycemic glucose concentrations up-regulate the expres-
sion of type VI collagen in vitro. Relevance to alterations of
peripheral nerves in diabetes mellitus. Am J Pathol 1993;142(5):
1586–97.
[35] Muona P, Jaakkola S, Salonen V, Peltonen J. Diabetes induces the
formation of large diameter collagen ﬁbrils in the sciatic nerves of BB
rats. Matrix 1989;9(1):62–7.
[36] Bradley JL, King RH, Muddle JR, Thomas PK. The extracellular
matrix of peripheral nerve in diabetic polyneuropathy. Acta Neuro-
path 2000;99:539–46.
[37] Halme T, Vihersaari T, Penttinen R. Lysyl oxidase activity and
synthesis of desmosines in cultured human aortic cells and skin
ﬁbroblasts: comparison of cell lines from control subjects and patients
with the Marfan syndrome or other annulo-aortic ectasia. Scand J
Clin Lab Invest 1986;46(1):31–7.
[38] Yamauchi M, London RE, Guenat C, Hashimoto F, Mechanic GL.
Structure and formation of a stable histidine-based trifunctional
cross-link in skin collagen. J Biol Chem 1987;262(24):11428–34.
[39] Cooper ME. Importance of advanced glycation end products in
diabetes-associated cardiovascular and renal disease. Am J Hypertens
2004;17(12 Pt 2):31S–8S.
[40] Stitt AW, Moore JE, Sharkey JA, Murphy G, Simpson DA, Bucala
R, et al. Advanced glycation end products in vitreous: Structural and
functional implications for diabetic vitreopathy. Invest Ophthalmol
Vis Sci 1998;39(13):2517–23.
[41] Sensi M, Pricci F, Andreani D, Di Mario U. Advanced nonenzymatic
glycation endproducts (AGE): their relevance to aging and the
pathogenesis of late diabetic complications. Diabetes Res
1991;16(1):1–9.
[42] Tanaka S, Avigad G, Brodsky B, Eikenberry EF. Glycation induces
expansion of the molecular packing of collagen. J Mol Biol
1988;203(2):495–505.
[43] Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S,







endproducts in cellular and extracellular proteins by tandem mass
spectrometry. Biochem J 2003;375(Pt 3):581–92.
[44] Monnier VM, Kohn RR, Cerami A. Accelerated age-related
browning of human collagen in diabetes mellitus. Proc Natl Acad
Sci USA 1984;81(2):583–7.
[45] Malik NS, Moss SJ, Ahmed N, Furth AJ, Wall RS, Meek KM.
Ageing of the human corneal stroma: structural and biochemical
changes. Biochim Biophys Acta 1992;1138(3):222–8.
[46] Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. Immuno-
chemical evidence for the presence of advanced glycation end
products in human lens proteins and its positive correlation with
aging. J Biol Chem 1992;267(15):10211–4.
[47] Meerwaldt R, Graaﬀ R, Oomen PH, Links TP, Jager JJ, Alderson
NL, et al. Simple non-invasive assessment of advanced glycation
endproduct accumulation. Diabetologia 2004;47(7):1324–30.
[48] Nagaraj RH, Sell DR, Prabhakaram M, Ortwerth BJ, Monnier VM.
High correlation between pentosidine protein cross-links and pig-
mentation implicates ascorbate oxidation in human lens senescence
and cataractogenesis. Proc Natl Acad Sci USA 1991;88(22):10257–61.
[49] Daniels HE. The statistical theory of the strength of bundles of
threads I. Proc R Soc Lond Ser A-Math Phys Sci 1945;183(995):
405–35.
[50] Ushiki T, Ide C. Three-dimensional organization of the collagen
ﬁbrils in the rat sciatic nerve as revealed by transmission- and
scanning electron microscopy. Cell Tissue Res 1990;260(1):175–84.
[51] Pins GD, Huang EK, Christiansen DL, Silver FH. Eﬀects of static
axial strain on the tensile properties and failure mechanisms of self-
assembled collagen ﬁbers. J Appl Polym Sci 1997;63(11):1429–40.
[52] Parkinson J, Brass A, Canova G, Brechet Y. The mechanical
properties of simulated collagen ﬁbrils. J Biomech 1997;30(6):549–54.
[53] Christiansen DL, Huang EK, Silver FH. Assembly of type I collagen:
fusion of ﬁbril subunits and the inﬂuence of ﬁbril diameter on
mechanical properties. Matrix Biol 2000;19(5):409–20.
[54] Hulmes DJS, Wess TJ, Prockop DJ, Fratzl P. Radial packing, order,
and disorder in collagen ﬁbrils. Biophys J 1995;68(5):1661–70.
[55] Hulmes DJ. Building collagen molecules, ﬁbrils, and supraﬁbrillar
structures. J Struct Biol 2002;137(1–2):2–10.
[56] Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical
detection of advanced glycosylation end products in vivo. J Biol
Chem 1992;267(8):5133–8.
[57] Bevington PR, Robinson DK. Data reduction and error analysis for
the physical sciences. 3rd ed., vol. xi. Boston, MA: McGraw-Hill;
2003. 320 p.
[58] Myers RR, Costello ML, Powell HC. Increased endoneurial ﬂuid
pressure in galactose neuropathy. Muscle Nerve 1979;2(4):299–303.
[59] Freeman JW, Silver FH. Elastic energy storage in unmineralized and
mineralized extracellular matrices (ECMs): a comparison between
molecular modeling and experimental measurements. J Theor Biol
2004;229(3):371–81.
[60] Misof K, Rapp G, Fratzl P. A new molecular model for collagen
elasticity based on synchrotron X-ray scattering evidence. Biophys J
1997;72(3):1376–81.
[61] Lorenzo AC, Caﬀarena ER. Elastic properties, Young’s modulus
determination and structural stability of the tropocollagen molecule:
a computational study by steered molecular dynamics. J Biomech
2005;38(7):1527–33.
[62] Fass JN, Odde DJ. Tensile force-dependent neurite elicitation via
anti-beta 1 integrin antibody-coated magnetic beads. Biophys J
2003;85(1):623–36.
[63] Ault HK, Hoﬀman AH. A composite micromechanical model for
connective tissues. 1. Theory. J Biomech Eng-Trans ASME
1992;114(1):137–41.
[64] Ault HK, Hoﬀman AH. A composite micromechanical model for
connective tissues. 2. Application to rat tail tendon and joint capsule.
J Biomech Eng-Trans ASME 1992;114(1):142–6.
[65] Toby EB, Rotramel J, Jayaraman G, Struthers A. Changes in the
stress relaxation properties of peripheral nerves after transection. J

























































B.E. Layton, A.M. Sastry / Acta Biomaterialia xxx (2006) xxx–xxx 13
ACTBIO 144 No. of Pages 13, Model 5+
4 July 2006 Disk Used
ARTICLE IN PRESS[66] Hurschler C, Loitz-Ramage B, Vanderby Jr R. A structurally based
stress-stretch relationship for tendon and ligament. J Biomech Eng
1997;119(4):392–9.
[67] Parry DA. The molecular and ﬁbrillar structure of collagen and its
relationship to the mechanical properties of connective tissue.
Biophys Chem 1988;29(1–2):195–209.
[68] Roeder BA, Kokini K, Sturgis JE, Robinson JP, Voytik-Harbin SL.
Tensile mechanical properties of three-dimensional type I collagen
extracellular matrices with varied microstructure. J Biomech Eng
2002;124(2):214–22.
[69] Haut RC, Little RW. Constitutive equation for collagen ﬁbers. J
Biomech 1972;5(5):423–30.
[70] Hoger A. The elasticity tensor of a transversely isotropic hyperelastic
material with residual stress. J Elasticity 1996;42(2):115–32.
[71] Kolowrocki K. Asymptotic approach to reliability evaluation of rope
transportation system. Reliab Eng Syst Saf 2001;71(1):57–64.
[72] Perry RJ. Estimating strength of the Williamsburg Bridge suspension
cables. Am Stat 1998;52(3):211–7.
[73] Hurschler C, LoitzRamage B, Vanderby R. A structurally based
stress–stretch relationship for tendon and ligament. J Biomech Eng-
Trans ASME 1997;119(4):392–9.
[74] Liao J, Yang L, Grashow J, Sacks MS. Molecular orientation of
collagen in intact planar connective tissues under biaxial stretch. Acta
Biomater 2005;1(1):45–54.
[75] Pradhan S, Chakrabarti BK, Hansen A. Crossover behavior in a
mixed-mode ﬁber bundle model. Phys Rev E 2005;71(3).
[76] Hidalgo RC, Moreno Y, Kun F, Herrmann HJ. Fracture model with

















[77] Galbraith JA, Thibault LE, Matteson DR. Mechanical and electrical
responses of the squid giant-axon to simple elongation. J Biomech
Eng-Trans ASME 1993;115(1):13–22.
[78] Wall EJ, Massie JB, Kwan MK, Rydevik BL, Myers RR, Garﬁn SR.
Experimental stretch neuropathy – changes in nerve-conduction
under tension. J Bone Joint Surg-Br 1992;74(1):126–9.
[79] Ogata K, Naito M. Blood-ﬂow of peripheral-nerve eﬀects of
dissection, stretching and compression. J Hand Surg-Br Eur 1986;
11B(1):10–4.
[80] Driscoll PJ, Glasby MA, Lawson GM. An in vivo study of peripheral
nerves in continuity: biomechanical and physiological responses to
elongation. J Orthop Res 2002;20(2):370–5.
[81] Takahara K, Sato Y, Okazawa K, Okamoto N, Noda A, Yaoi Y,
et al. Complete primary structure of human collagen alpha 1 (V)
chain. J Biol Chem 1991;266(20):13124–9.
[82] Traub W, Steinmann B. Structural study of a mutant type I collagen
from a patient with lethal osteogenesis imperfecta containing an
intramolecular disulﬁde bond in the triple-helical domain. FEBS Lett
1986;198(2):213–6.
[83] Rainey JK, Goh MC. A statistically derived parameterization for the
collagen triple-helix. Protein Sci 2002;11(11):2748–54.
[84] Ottani V, Martini D, Franchi M, Ruggeri A, Raspanti M. Hierar-
chical structures in ﬁbrillar collagens. Micron 2002;33(7–8):587–96.
[85] Ushiki T, Ide C. Three-dimensional architecture of the endoneurium
with special reference to the collagen ﬁbril arrangement in relation to
nerve ﬁbers. Arch Histol Japon 1986;49(5):553–63.
[86] Puxkandl R, Zizak I, Paris O, Keckes J, Tesch W, Bernstorﬀ S, et al.
Viscoelastic properties of collagen: synchrotron radiation investiga-
tions and structural model. Philos Trans R Soc Lond B Biol Sci
2002;357(1418):191–7.E
